Evaluation of an "Opt-Out" Inpatient Smoking Cessation Service on Smoking Behavior Study #1
NCT ID: NCT04827914
Last Updated: 2025-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
1122 participants
INTERVENTIONAL
2021-03-08
2026-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Smoking Cessation in Hospitalized Smokers
NCT01289275
Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness
NCT02845440
Web-based Smoking Cessation Intervention: Transition From Inpatient to Outpatient
NCT01277250
Proactive Outreach for Smoking Treatment
NCT04988477
Working Inside for Smoking Elimination
NCT01122589
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Enhanced Care Condition
Enhanced Care
Smokers in the enhanced care group will receive live counseling (either in person or telehealth consult) while hospitalized combined with post-hospital discharge automated calls using interactive voice recognition (IVR) technology.
Basic Care Condition
Basic Care
Smokers assigned to the basic care group will only receive the post-discharge IVR phone calls.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enhanced Care
Smokers in the enhanced care group will receive live counseling (either in person or telehealth consult) while hospitalized combined with post-hospital discharge automated calls using interactive voice recognition (IVR) technology.
Basic Care
Smokers assigned to the basic care group will only receive the post-discharge IVR phone calls.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hospitalized cigarette smokers eligible for either enhanced or basic care
* discharged from the hospital back to their home
Exclusion Criteria
* those unable to communicate in the English language
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of South Carolina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenneth M Cummings, PhD
Role: PRINCIPAL_INVESTIGATOR
Medical University of South Carolina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Psychiatry
Charleston, South Carolina, United States
MUSC
Charleston, South Carolina, United States
MUSC
Chester, South Carolina, United States
MUSC
Florence, South Carolina, United States
MUSC
Lancaster, South Carolina, United States
MUSC
Marion, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
107000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.